Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00408759|
Recruitment Status : Unknown
Verified December 2006 by Bnai Zion Medical Center.
Recruitment status was: Recruiting
First Posted : December 7, 2006
Last Update Posted : December 7, 2006
xerostomia develops in all patients with head and neck cancer following radiotherapy. it consists one of the main side effects which affects quality of life. currently, there is no standard of care for treating this condition. parasympathomimetic drugs may help but carry significant side effects.
hypnosis may affect autonomic function such as salivation, in healthy people.in this study we will explore the efficacy of hypnosis in improving salivation, in the patient population.
|Condition or disease||Intervention/treatment||Phase|
|Xerostomia||Behavioral: hypnosis||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Phase 2 Study of Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients|
|Study Start Date :||November 2006|
|Study Completion Date :||December 2006|
- salivaa volume
- quality of life related to salivation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00408759
|Contact: elad firstname.lastname@example.org|
|Contact: gorge email@example.com|
|bnai zion MC||Recruiting|
|Contact: elad schiff 97248359767 firstname.lastname@example.org|
|Sub-Investigator: Gorge Mogilner|
|Sub-Investigator: Noam Yarom|
|Sub-Investigator: Ilana Dowek|
|Principal Investigator:||Elad Schiff||Bnai Zion MC|